1-10 of 10
Lara Aprile
Close
Sort by
Journal Articles

First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response

Michele Malagola, MD, Fabio Efficace, PhD, Nicola Polverelli, MD, Elisabetta Abruzzese, Alessandra Iurlo, Cristina Bucelli, MD, Fabio Stagno, Massimiliano Bonifacio, Mariella D'adda, MD, Monia Lunghi, Monica Crugnola, MD, Francesca Lunghi, Fausto Castagnetti, Gianantonio Rosti, Ferrari Maria Luisa, Micaela Bergamaschi, MD, Gianni Binotto, MD, Rosaria Sancetta, MD, Maria Rosaria Coppi, Valentina Giai, Giovanna Rege Cambrin, MD, Atelda Romano, Mario Tiribelli, Sabina Russo, Lara Aprile, Antonietta Pia Falcone, MD, Serena Rupoli, MD, Antonella Russo Rossi, MD, Emilio Usala, MD, Bruno Martino, MD, Lisa Gandolfi, Simona Bernardi, PhD, Camilla Zanaglio, PhD, Mirko Farina, MD, Michele Baccarani, MD, Domenico Russo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4251.
https://doi.org/10.1182/blood-2018-99-110250
Published: 2018
Journal Articles

Persistence of Residual Circulating CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients in Treatment Free Remission

Monica Bocchia, Marzia Defina, Santina Sirianni, Bruno Martino, Elisabetta Abruzzese, MD, Patrizia Pregno, MD, Sara Galimberti, PhD MD, Giulia Alunni, Anna Sicuranza, Antonella Gozzini, MD, Carmen Fava, MD PhD, Luca Puccetti, Federica Sorà, MD, Claudia Baratè, MD PhD, Fausto Castagnetti, MD PhD, Lara Aprile, Alessandra Iurlo, MD PhD, Daniele Cattaneo, MD, Simona Sica, MD, Luigiana Luciano, Monica Crugnola, MD, Mario Annunziata, MD, Giovanni Caocci, MD, Olga Mulas, Emilio Usala, MD, Nicola Sgherza, Gianantonio Rosti, MD, Donatella Raspadori
Journal: Blood
Blood (2017) 130 (Supplement 1): 249.
https://doi.org/10.1182/blood.V130.Suppl_1.249.249
Published: 2017
Journal Articles

Role of Erythropoietin in the Late Anemia of Patients with Chronic Myeloid Leukemia Treated Frontline with Imatinib

Laura Cesini, Camilla Frieri, MD, Claudia Baratè, MD PhD, Federica Sorà, MD, Marco Cerrano, Antonia Cagnetta, MD, Lara Aprile, Nicola Sgherza, Malgorzata Monika Trawinska, Antonella Gozzini, MD, Ida Carmosino, Federica Ricci, MD, Monica Bocchia, Micaela Bergamaschi, MD, Chiara Aguzzi, MD, Simona Sica, MD, Sara Galimberti, PhD MD, Massimo Breccia, MD PhD, Fabrizio Pane, MD, Luigiana Luciano, Roberto Latagliata
Journal: Blood
Blood (2017) 130 (Supplement 1): 2884.
https://doi.org/10.1182/blood.V130.Suppl_1.2884.2884
Published: 2017
Journal Articles

Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy

Monica Bocchia, Lara Aprile, Santina Sirianni, Elisabetta Abruzzese, MD, Antonella Gozzini, MD, Fausto Castagnetti, MD, Luca Puccetti, Federica Sorà, Sara Galimberti, MD PhD, Anna Sicuranza, Mario Tiribelli, MD, Massimo Breccia, MD, Alessandra Iurlo, MD, Giulia Bartalucci, Daniele Cattaneo, MD, Olga Mulas, Claudia Baratè, Giovanni Caocci, MD, Simona Sica, Gianantonio Rosti, MD, Alberto Bosi, Donatella Raspadori
Journal: Blood
Blood (2016) 128 (22): 942.
https://doi.org/10.1182/blood.V128.22.942.942
Published: 2016
Journal Articles

The hOCT1 and ABCB1 Polymorphisms Don't Condition the Efficacy and Toxicity of Nilotinib As First-Line Treatment: An Italian Multicentric Experience

Sara Galimberti, MD PhD, Cristina Bucelli, MD, Elena Arrigoni, PhD, Claudia Baratè, Susanna Grassi, Federica Ricci, MD, Francesca Guerrini, PhD, Elena Ciabatti, PhD, Carmen Fava, MD, Antonio D'Avolio, Giulia Fontanelli, MD, Giovanna Rege Cambrin, MD, Alessandro Isidori, MD PhD, Federica Loscocco, PhD, Giovanni Caocci, MD, Marianna Greco, PhD, Monica Bocchia, MD, Lara Aprile, MD, Antonella Gozzini, MD, Barbara Scappini, MD, Daniele Cattaneo, MD, Giorgio La Nasa, MD, Alberto Bosi, MD, Mario Petrini, MD PhD, Pietro Leoni, MD, Romano Danesi, MD PhD, Giuseppe Saglio, MD PhD, Giuseppe Visani, MD, Agostino Cortellezzi, MD, Anna Rita Scortechini, MD, Alessandra Iurlo, MD, Antonello Di Paolo, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3951.
https://doi.org/10.1182/blood.V128.22.3951.3951
Published: 2016
Journal Articles

Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib

Sara Galimberti, MD PhD, Laura Galeotti, PhD, Francesco Ceccherini, PhD, Marialuisa Polillo, Dr, Claudia Baratè, MD, Giulia Fontanelli, MD, Francesca Guerrini, PhD, Roberta Arici, ScD, Sara Barsotti, MD, Federica Ricci, Lara Aprile, MD, Fulvio Cornolti, Prof., Mario Petrini, MD, Monica Bocchia, MD PhD Prof., Antonello Di Paolo, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3608.
https://doi.org/10.1182/blood.V124.21.3608.3608
Published: 2014
Journal Articles

Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status?

Lara Aprile, Luca Puccetti, Sara Galimberti, Antonella Gozzini, Francesca Scarpini, Marzia Defina, Federica De Majo, Claudia Baratè, Anna Sicuranza, Veronica Candi, Barbara Scappini, Donatella Raspadori, Alessandro Gozzetti, Alberto Bosi, Mario Petrini, Monica Bocchia
Journal: Blood
Blood (2013) 122 (21): 1482.
https://doi.org/10.1182/blood.V122.21.1482.1482
Published: 2013
Journal Articles

Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy.

Monica Bocchia, Marzia Defina, Micaela Ippoliti, Elisabetta Abruzzese, Fausto Castagnetti, Mario Tiribelli, Gianantonio Rosti, Massimo Breccia, MD, Malgorzata Monika Trawinska, Rosaria Crupi, Lara Aprile, Marzia Salvucci, Claudia Baratè, Antonella Gozzini, Michela Rondoni, Alfonso Zaccaria, Giuliana Alimena, MD, Valeria Santini, Giorgina Specchia, Renato Fanin, Alessandro Gozzetti, Francesco Lauria, MD
Journal: Blood
Blood (2010) 116 (21): 3413.
https://doi.org/10.1182/blood.V116.21.3413.3413
Published: 2010
Journal Articles

Four Drugs Combination (Fludarabine, Cytarabine, Idarubicin, Etoposide) as Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia Patients Younger Than 65 Ys: Response and Follow-up of 84 Patients.

Michela Rondoni, Michele Malagola, Stefania Paolini, Marzia Defina, Pier Paolo Piccaluga, Lara Aprile, Cristina Papayannidis, Nicoletta Testoni, Rosaria Crupi, Alessandro Gozzetti, Monica Tozzi, Giuseppe Marotta, Francesca Toraldo, Domenico Russo, Monica Bocchia, Michele Baccarani, MD, Giovanni Martinelli, Francesco Lauria, MD
Journal: Blood
Blood (2009) 114 (22): 4147.
https://doi.org/10.1182/blood.V114.22.4147.4147
Published: 2009
Journal Articles

BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial.

Monica Bocchia, Marzia Defina, Micaela Ippoliti, Marilina Amabile, Massimo Breccia, Francesco Iuliano, Marco Vignetti, Gabriele Gugliotta, Antonella Russo Rossi, Giuliana Alimena, Lara Aprile, Gianluca Gaidano, Paolo Nicoli, Malgorzata Monika Trawinska, Renato Bassan, Diamante Turri, Laura Cannella, Luigia Luciano, Alessandro Gozzetti, Michela Rondoni, Gianantonio Rosti, Giovanni Martinelli, Michele Baccarani, MD, Francesco Lauria, MD
Journal: Blood
Blood (2009) 114 (22): 648.
https://doi.org/10.1182/blood.V114.22.648.648
Published: 2009